Clínica Universidad de Navarra (CUN)

Centro clínico de la Universidad de Navarra

Foto de Clínica Universidad de Navarra (CUN)

Foto de Centre François Baclesse

Centre François Baclesse

Esch-sur-Alzette, Luxemburgo

Publications en collaboration avec des chercheurs de Centre François Baclesse (6)

2024

Acute kidney disease beyond day 7 after major surgery: a secondary analysis of the EPIS-AKI trial
Intensive Care Medicine, Vol. 50, Núm. 2, pp. 247-257

2023

Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study
Intensive Care Medicine, Vol. 49, Núm. 12, pp. 1441-1455

2021

Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1–Positive Advanced NSCLC
Journal of Thoracic Oncology

2020

Long-term outcomes and retreatment among patients with previously treated, programmed death-ligand 1‒positive, advanced non‒small-cell lung cancer in the KEYNOTE-010 study
Journal of Clinical Oncology, Vol. 38, Núm. 14, pp. 1580-1591
Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer
Gynecologic Oncology, Vol. 159, Núm. 1, pp. 142-149

2016

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): A randomised controlled trial
The Lancet, Vol. 387, Núm. 10027, pp. 1540-1550